71 |
Characterisation of the Group A Streptococcus M and M-like proteins as potential vaccine antigensFrost, Hannah 25 May 2020 (has links) (PDF)
Group A Streptococcus (GAS) is a human specific bacterial pathogen which causes a variety of diseases and is responsible for significant mortality worldwide. GAS are known to interact with the immune system, notably by binding host serum proteins to the bacterial surface.Many of these binding functions are attributed to the GAS M protein, the archetypal GAS virulence factor, the substrate for GAS typing and the leading GAS vaccine candidate. The vast diversity of GAS strains has however made vaccine development challenging. We investigated the potential for cross-protective immunity within closely related strains in a clinical setting in Fiji. This study has shown that immunity to GAS skin infection was broader than previously believed and included some level of cross-opsonisation betweenGAS strains. The level of such cross-opsonisation was, however, variable among GAS lineages. We have also shown that the immunity to conserved M antigens was quite variable. These results inspired us to investigate other suitable vaccine antigens. We hypothesised that in cases where the M protein was less immunodominant, perhaps closely related M-like proteins played an important role in immunity. We therefore began global characterisation ofthe two major M-like proteins, called Mrp and Enn. A representative worldwide genomic collection including more than 2000 isolates originating from multiple continents and various clinical manifestations has been established collaboratively. We focused our analyses on theMga regulon which encodes M and M-like proteins. We found that mrp and enn genes were present in 85% of genomes suggestive of their importance to GAS survival and spread. We developed molecular definitions of the different genes families, clarifying nomenclature forthe worldwide reference laboratory at the American CDC. We established and validated an updated, more specific typing protocol for GAS which will reduce future misclassifications. We have also analysed the genetic linkage between M and M-like protein alleles and developed clusters of closely related protein sequences. By characterising this complex and variable genetic region, we provide a framework for future functional investigations. Finally, we began functional characterisation of Enn proteins by investigating the differential capacity of Enn proteins to bind to C4BP, an inhibitor of complement. Altogether our results suggest M-like proteins play an important role in GAS virulence and should not be neglected. These data support further functional analyses to better understand the contribution of M-like proteins to GAS infection. / Doctorat en Sciences biomédicales et pharmaceutiques (Médecine) / info:eu-repo/semantics/nonPublished
|
72 |
Nanopore Sensing of PCR-Amplified Pathogenic DNAKing, Simon 15 March 2022 (has links)
Solid-state nanopore sensors are an emerging platform for performing single-molecule characterization of biomolecules such as DNA. With the advent of Controlled Breakdown (CBD), creating a simple, tunable, ultra-low concentration sensing device in situ has enabled their direct integration with a host of platforms. The simplicity and sensitivity in performing measurements allows nanopore-based technologies to find uses which enhance existing methods.
One such promising avenue for nanopore-based sensing is in the detection of infectious diseases, where early and accurate identification of the causative pathogen is essential for successful patient outcomes. Conventional assays, while effective, often have limitations in speed, cost, or target sensitivity, and may benefit from nanopore sensing approaches. However, solid-state nanopores currently lack the ability to discriminate between biomarkers sharing identical size and charge densities, such as sequentially-heterogeneous strands of DNA.
Addressing the weakness of both conventional assays and nanopores could come from combining nanopore sensing with the polymerase chain reaction (PCR), a well-established and highly-selective nucleic acid amplification scheme. PCR is designed to produce large quantities of identical fragments of DNA, known as amplicons, if a user-defined parent copy is present. After the PCR process has finished, the signals produced by this population of amplicons on a nanopore sensor should therefore be indicative to the presence of a DNA biomarker in the starting sample.
As PCR reactions can use a mix of different proteins, detergents, and other molecules, the challenge lies in ensuring the compatibility of these reagents with a nanopore, and determining whether the background signal they produce can be discriminated from an amplicon signal. To this end, this thesis investigates PCR-nanopore compatibility, and experimentally demonstrates a nanopore signal-classification technique to successfully identify the presence of chromosomal DNA from Group A Streptococcus (GAS), an infectious bacterium responsible for strep throat, in samples derived from clinical extracts.
|
73 |
Mouse Antibody Response to Group A Streptococcal Carbohydrate: A ThesisJarvis, Christopher D. 01 May 1989 (has links)
In an attempt to more fully understand the generation of antibody diversity to carbohydrate antigens, we produced and characterized a panel of hybridoma cell lines specific for group A streptococcal carbohydrate from mice injected with the intact bacteria (minus the hyaluronic acid capsule and cell wall protein antigens). We have analyzed the use of heavy and light chain variable region genes in the early (day 7) and late response (hyperimmune) and have determined the nucleotide sequence of the dominant VH gene used in several of our hybridomas. Our data allowed us to assess the extent to which the recombination of various V, D, and J gene segments and somatic mutation contribute to antibody diversification in this system. In this report we confirm that a minimum of two VH and four VK gene segments are used to encode this response. We extend this analysis to show that multiple D and J gene segments are used and that a significant amount of junctional variability is tolerated in CDR 3. Our results also suggest that there is a positive selection for somatic mutation in CDR 1 during the hyperimmune response to group A streptococcal carbohydrate.
|
74 |
Attachment of Streptococcus pyogenes to Host Epithelial CellsSethman, Chad Robert 19 December 2003 (has links)
No description available.
|
75 |
Febre reumática: Perfis imunoquímicos desenvolvidos por antígenos celulares e extracelulares do Streptococcus pyogenes e isotipos de anticorpos de pacientes com a doença / Rheumatic fever: Immunochemical profiles developed by cellular and extracellular antigens of Streptococcus pyogenes and antibody isotypes from patients with the diseasePavan, Maria de Fatima Borges 05 December 1996 (has links)
A febre reumática é uma das sequelas da infecção causada por Streptococcus pyogenes, afetando notadamente crianças e jovens, com altas taxas de morbidade e mortalidade em várias regiões do mundo, incluindo Brasil. Perfis imunoquímicos desenvolvidos por antígenos celulares e extracelulares desta bactéria e isotipos de anticorpos presentes em pacientes com febre reumática foram averiguados, em virtude da escassez de informação a este respeito na literatura. Na primeira fase do trabalho, as condições para o preparo de antígenos, bem como de técnicas, em especial a técnica super-micro de neutralização de anticorpos (Ac) anti-estreptolisina O (ASLO) foram padronizadas. Na segunda etapa, foram identificadas as bandas de antígenos celulares e extracelulares reconhecidas por 56 soros de pacientes com febre reumática (Grupo A), 91 soros de indivídos sem diagnóstico de sequelas não-supurativas da infecção, mas com títulos baixos, médios e altos de Ac ASLO (Grupo B), e 41 soros de crianças sem infecção (Grupo C). Em pacientes com febre reumática, Acs IgG e IgA foram detectados, mas Acs IgM não foram encontrados. Anticorpos IgG de pacientes do grupo A reconheceram um total de 30 bandas do antígeno celular, sendo específicas 18 (14, 17, 19,22,23,28,29,32,36, 73, 83, 102, 104, 108, 11 0, 116, 118 e 125 kDa). O resto das 12 bandas foram consideradas não específicas por serem reconhecidas por soros do grupo C. Um total de 19 bandas do antígeno extracelular foi reconhecido por Acs IgG do grupo A, sendo apenas 3 bandas (40, 46, 125 kDa) específicas. No grupo C, Acs IgA não foram detectados. Um total de 14 bandas (23, 30, 38, 42, 43, 46, 48, 54, 57, 60, 67, 73, 78 e 116 kDa) do antígeno celular foram identificadas por Acs IgA do grupo A. No antígeno extracelular, 8 bandas (38, 48, 54, 60, 67,\" 73, 78 e 95 kDa) foram reconhecidas por Acs IgA do mesmo grupo. Critério adotado de combinar dados imunoquímicos ou seja, bandas iguais ou maiores que 102 kDa e/ou bandas iguais ou menores que 29 kDa do antígeno celular de S. pyogenes, acrescido da presença de Acs IgA, possibilitaram a discriminação de pacientes com febre reumática e de não infectados, fornecendo máxima sensibilidade, especificidade, eficiência, bem como de valores preditivos de resultados positivo e negativo. Ademais, os achados de Acs IgG contra banda de 28 kDa que está relacionada a antígeno do tecido cardíaco, um dos 6 perfís imunoquímicos fornecidos por antígeno celular e Acs IgG do presente estudo, e a presença de Acs IgA parecem constituir sinais precoces associados à patogênese da febre reumática. Desta forma no grupo B, 9 pacientes revelaram a banda de 23 kDa do antígeno celular, destes 7 apresentaram perfis compatíveis com os do grupo A, sendo que apenas 1 deles não apresentou Acs IgA. Os dados sugerem que estes pacientes tendem a evoluir para a forma sintomática da febre reumática, requerendo acompanhamento clínico e laboratorial cuidadoso. / The rheumatic fever is one of the sequelae from the Streptococcus pyogenes infection, affecting manly children and young persons, with high rates of morbidity and mortality in many regions of the world. Immunological profiles developed by cellular and extracellular antigens from this bacterium and antibody isotypes found in the patients with rheumatic fever were investigated, due to the scarcity of information about this aspect in the literature. In the first step of this work, conditions to prepare antigens, as well as of techniques, in particular the super-micro technique for the neutralization of antistreptolysin O (ASLO) antibodies (Abs), were standardized. In the second step, bands of cellular and extracellular antigens recognized by 56 serum sera from patients with rheumatic fever (Grupo A), 91 sera from individuals with no diagnosis of supurative sequelae from the infection, but with low, moderate and high ASLO titers (Group B), and 41 sera from children with no infection (Group C) were identified. In patients with rheumatic fever, IgG and IgA antibodies were found, but IgM antibodies were absent. IgG antibodies from rheumatic fever patients recognized 30 bands of the cellular antigens, of these 18 were specific (14,17,19,22,23,28,29,32,36,73,83,102, 104, 108, 110, 116, 118 e 125 kDa). The remaing 12 bands were considered nonspecific because they were recognized by sera from the group C. A total of 19 bands of the extracellular antigen were recognized by IgG Abs from the group A and 3 of these (40, 46 and 125 kDa) were specific. In the group C, no IgA Abs were detected. A total of 14 specific bands (23, 30, 38, 42, 43, 46, 48, 54, 57, 60, 67, 73, 78 and 116 kDa) of the cellular antigen were identified by IgA Abs from the group A. The extracellular antigen had 8 bands (38, 48, 54, 60, 67, 73, 78 and 95 kDa) recognized by IgA Abs from the same group. A criterion adopted of combining immunchemical data, i.e. bands equal or higher than 102 kDa and/or bands equal or lower than 29 kDa of the cellular antigen of S. pyogenes plus the IgA Ab finding, allowed to discriminate rheumatic fever from noninfected individuals, providing maximum sensitivity, specificity, efficiency as well as predictives of positive and negative results. Moreover, the findings of IgG Abs to 23 kDa of the cellular antigen which is associated to the heart tissue antigen, one of those 6 immunochemical profiles provided by cellular antigen and IgG Abs from this study, and the presence of IgA Abs seem to constitute early immunologic signals related to the pathogenesis of the rhematic fever. Thus in the group B, 9 patients revealed a 23 kDa band of cellular antigen, 7 of these showed immunochemical profiIes consistent with those from the group A, and lacking IgA Abs in onIy one of them. The data suggest these patients are prone to deveIop rheumatic fever, requiring a close clinical and laboratory follow-up.
|
76 |
Etude de la biodiversité des souches de Streptococcus pyogenes responsables d'infections invasives et de cas groupés par une approche de génomique comparative / Biodiversity study of Streptococcus pyogenes strains responsible for invasive infections and clusters by a comparative genomic approachPlainvert, Céline 15 November 2013 (has links)
Streptococcus pyogenes (Streptocoque du Groupe A (SGA)) est un germe humain responsable d’un large éventail de pathologies invasives et non-invasives, mais aucun attribut génétique ne rend compte à lui seul de cette diversité. Notre objectif a été de rechercher des liens entre génotype, présence de gènes de virulence et caractère invasif des souches par une approche d’épidémiologie moléculaire. Une association entre génotypes et présence de certains gènes de virulence a été établie sur une collection de souches françaises de SGA responsables d’infections invasives chez des adultes. De même, la présence du locus sil, codant un système de quorum-sensing, est liée au génotype des souches, mais non à leur caractère invasif. Concernant la réponse immunitaire innée, contrairement aux souches emm1, emm4 et emm28, les souches invasives emm3 et emm89 sont plus phagocytées par les macrophages que leurs homologues non-invasives. Les souches emm89 sont plus phagocytées et survivent plus longtemps dans les macrophages que les souches des autres génotypes. Par ailleurs, les souches emm3 induisent l’apoptose des macrophages. Enfin, la cinétique de production des médiateurs pro et anti-inflammatoires est dépendante du génotype. La souche de colonisation d’un cas groupé, incluant aussi une souche invasive, présente une mutation originale dans covS (codant le senseur d’un système de régulation à deux composants). La protéine CovSY39H répond peu aux signaux de l’environnement, correspondant à une protéine CovS constitutive. Le phénotype de ce mutant, résultant de l’expression de certains gènes de virulence, est favorable à la colonisation. Sa survie dans les macrophages et sa virulence sont altérées. / Streptococcus pyogenes (Group A Streptococcus (GAS)) is a human pathogen responsible for a wide range of diseases including non-invasive and invasive infections. To date no specific GAS attribute has been associated with a type of infection although a link between genetic background and tissue tropism has been demonstrated. Our objective was to investigate the relationship between genotype, the presence of genes encoding virulence factors and invasive strains by molecular epidemiology approach. An association between genotypes and the presence of genes encoding virulence factors has been established among a collection of French strains responsible for invasive GAS infections in adults. Similarly, the presence of sil locus, encoding a quorum sensing system, is related to genotype, but not to the invasive status of the GAS strains. Regarding the innate immune response, unlike emm1, emm4 and emm28 strains, invasive emm3 and emm89 strains are more phagocytosed by macrophages than their non-invasive counterparts. The emm89 strains are phagocytosed and survive longer in macrophages than strains belonging to any other genotype. Moreover, emm3 strains induce macrophage apoptosis. Finally, the kinetics of production of pro- and anti-inflammatory mediators are genotype-dependent. A colonization strain belonging to a cluster that also includes an invasive strain, has a unique mutation in covS (encoding the sensor of a two-component system). The CovSY39H protein responds less to some environmental signals, corresponding to a constitutive CovS protein. The phenotype of the mutant, resulting in the expression of certain genes encoding virulence factors, favors a colonization state. Survival in macrophages and virulence are also altered.
|
77 |
Febre reumática: Perfis imunoquímicos desenvolvidos por antígenos celulares e extracelulares do Streptococcus pyogenes e isotipos de anticorpos de pacientes com a doença / Rheumatic fever: Immunochemical profiles developed by cellular and extracellular antigens of Streptococcus pyogenes and antibody isotypes from patients with the diseaseMaria de Fatima Borges Pavan 05 December 1996 (has links)
A febre reumática é uma das sequelas da infecção causada por Streptococcus pyogenes, afetando notadamente crianças e jovens, com altas taxas de morbidade e mortalidade em várias regiões do mundo, incluindo Brasil. Perfis imunoquímicos desenvolvidos por antígenos celulares e extracelulares desta bactéria e isotipos de anticorpos presentes em pacientes com febre reumática foram averiguados, em virtude da escassez de informação a este respeito na literatura. Na primeira fase do trabalho, as condições para o preparo de antígenos, bem como de técnicas, em especial a técnica super-micro de neutralização de anticorpos (Ac) anti-estreptolisina O (ASLO) foram padronizadas. Na segunda etapa, foram identificadas as bandas de antígenos celulares e extracelulares reconhecidas por 56 soros de pacientes com febre reumática (Grupo A), 91 soros de indivídos sem diagnóstico de sequelas não-supurativas da infecção, mas com títulos baixos, médios e altos de Ac ASLO (Grupo B), e 41 soros de crianças sem infecção (Grupo C). Em pacientes com febre reumática, Acs IgG e IgA foram detectados, mas Acs IgM não foram encontrados. Anticorpos IgG de pacientes do grupo A reconheceram um total de 30 bandas do antígeno celular, sendo específicas 18 (14, 17, 19,22,23,28,29,32,36, 73, 83, 102, 104, 108, 11 0, 116, 118 e 125 kDa). O resto das 12 bandas foram consideradas não específicas por serem reconhecidas por soros do grupo C. Um total de 19 bandas do antígeno extracelular foi reconhecido por Acs IgG do grupo A, sendo apenas 3 bandas (40, 46, 125 kDa) específicas. No grupo C, Acs IgA não foram detectados. Um total de 14 bandas (23, 30, 38, 42, 43, 46, 48, 54, 57, 60, 67, 73, 78 e 116 kDa) do antígeno celular foram identificadas por Acs IgA do grupo A. No antígeno extracelular, 8 bandas (38, 48, 54, 60, 67,\" 73, 78 e 95 kDa) foram reconhecidas por Acs IgA do mesmo grupo. Critério adotado de combinar dados imunoquímicos ou seja, bandas iguais ou maiores que 102 kDa e/ou bandas iguais ou menores que 29 kDa do antígeno celular de S. pyogenes, acrescido da presença de Acs IgA, possibilitaram a discriminação de pacientes com febre reumática e de não infectados, fornecendo máxima sensibilidade, especificidade, eficiência, bem como de valores preditivos de resultados positivo e negativo. Ademais, os achados de Acs IgG contra banda de 28 kDa que está relacionada a antígeno do tecido cardíaco, um dos 6 perfís imunoquímicos fornecidos por antígeno celular e Acs IgG do presente estudo, e a presença de Acs IgA parecem constituir sinais precoces associados à patogênese da febre reumática. Desta forma no grupo B, 9 pacientes revelaram a banda de 23 kDa do antígeno celular, destes 7 apresentaram perfis compatíveis com os do grupo A, sendo que apenas 1 deles não apresentou Acs IgA. Os dados sugerem que estes pacientes tendem a evoluir para a forma sintomática da febre reumática, requerendo acompanhamento clínico e laboratorial cuidadoso. / The rheumatic fever is one of the sequelae from the Streptococcus pyogenes infection, affecting manly children and young persons, with high rates of morbidity and mortality in many regions of the world. Immunological profiles developed by cellular and extracellular antigens from this bacterium and antibody isotypes found in the patients with rheumatic fever were investigated, due to the scarcity of information about this aspect in the literature. In the first step of this work, conditions to prepare antigens, as well as of techniques, in particular the super-micro technique for the neutralization of antistreptolysin O (ASLO) antibodies (Abs), were standardized. In the second step, bands of cellular and extracellular antigens recognized by 56 serum sera from patients with rheumatic fever (Grupo A), 91 sera from individuals with no diagnosis of supurative sequelae from the infection, but with low, moderate and high ASLO titers (Group B), and 41 sera from children with no infection (Group C) were identified. In patients with rheumatic fever, IgG and IgA antibodies were found, but IgM antibodies were absent. IgG antibodies from rheumatic fever patients recognized 30 bands of the cellular antigens, of these 18 were specific (14,17,19,22,23,28,29,32,36,73,83,102, 104, 108, 110, 116, 118 e 125 kDa). The remaing 12 bands were considered nonspecific because they were recognized by sera from the group C. A total of 19 bands of the extracellular antigen were recognized by IgG Abs from the group A and 3 of these (40, 46 and 125 kDa) were specific. In the group C, no IgA Abs were detected. A total of 14 specific bands (23, 30, 38, 42, 43, 46, 48, 54, 57, 60, 67, 73, 78 and 116 kDa) of the cellular antigen were identified by IgA Abs from the group A. The extracellular antigen had 8 bands (38, 48, 54, 60, 67, 73, 78 and 95 kDa) recognized by IgA Abs from the same group. A criterion adopted of combining immunchemical data, i.e. bands equal or higher than 102 kDa and/or bands equal or lower than 29 kDa of the cellular antigen of S. pyogenes plus the IgA Ab finding, allowed to discriminate rheumatic fever from noninfected individuals, providing maximum sensitivity, specificity, efficiency as well as predictives of positive and negative results. Moreover, the findings of IgG Abs to 23 kDa of the cellular antigen which is associated to the heart tissue antigen, one of those 6 immunochemical profiles provided by cellular antigen and IgG Abs from this study, and the presence of IgA Abs seem to constitute early immunologic signals related to the pathogenesis of the rhematic fever. Thus in the group B, 9 patients revealed a 23 kDa band of cellular antigen, 7 of these showed immunochemical profiIes consistent with those from the group A, and lacking IgA Abs in onIy one of them. The data suggest these patients are prone to deveIop rheumatic fever, requiring a close clinical and laboratory follow-up.
|
78 |
Infektionen pädiatrischer Patienten durch Streptokokken der Gruppe A: Klinische Charakteristika und molekular-epidemiologische ErregeranalyseKonrad, Peter 14 July 2021 (has links)
Obwohl seit der Einführung des Penicillins ein wirksames Medikament gegen Streptokokken der Lancefield Gruppe A (GAS) existiert, bei welchem bislang keine Resistenzen beschrieben wurden, bleiben GAS-Infektionen auch heute noch ein großes gesundheitspolitisches Problem, das sowohl die Morbidität als auch die Mortalität der Menschen weltweit beeinflusst. GAS können ein breites Spektrum an Erkrankungen beim Menschen verursachen. Dazu zählen nicht nur unkomplizierte Racheninfektionen mit und ohne Scharlach oder Hautinfektionen wie Erysipel oder Impetigo, sondern auch invasive sowie Folgeerkrankungen.
1928 wurde als Typ-spezifische, Antikörperbildung-induzierende Substanz das M-Protein beschrieben, welches durch das emm-Gen kodiert und seither zur Beschreibung der Epidemiologie von GAS verwendet wird. Eine der Hauptfunktionen des auf der Oberfläche von GAS verankerten M-Proteins besteht darin, die Phagozytose durch polymorphkernige Leukozyten zu verhindern, was zu den wichtigsten Abwehrmechanismen von Infektionen mit GAS gezählt wird. Obwohl seit einigen Jahrzehnten große Anstrengungen unternommen wurden, bleibt ein sicherer und effektiver Impfstoff bisher ein unerreichtes Ziel. In der hier vorliegenden Studie wurde, anhand der über den Zeitraum vom 11.03.2006 bis 19.05.2012 am Universitätsklinikum Freiburg gesammelten Daten und Isolaten, die regionale Epidemiologie von Infektionen pädiatrischer Patienten durch GAS retrospektiv untersucht. Mit insgesamt 566 Isolaten und zugehörigen klinischen Daten stellt diese Studie die bisher größte unizentrische epidemiologische Untersuchung von pädiatrischen Erkrankungen mit emm-Typisierung von GAS in Deutschland dar. Dabei wurde besonders auf Zusammenhänge zwischen den molekularepidemiologischen Daten, basierend auf der emm-Typisierung, und den anonymisierten klinischen Informationen eingegangen. In die Kohorte konnten insgesamt 566 Fälle eingeschlossen werden. Bei 405 Fällen wurde eine Racheninfektion festgestellt, wovon bei wiederum 75 Fällen zusätzlich die Diagnose Scharlach gestellt wurde, 34 Kinder stellten sich mit einer Hautinfektion vor, 21 mit einer akuten Otitis media, 19 mit einer anogenitalen Infektion, acht mit einer invasiven Infektion und zwei mit einer Harnwegsinfektion. Als Kolonisation durch GAS ohne Krankheitswert wurden 77 Fälle gewertet, davon 48 mit pharyngealer Kolonisation. In der molekularepidemiologischen Untersuchung konnten drei neue emm-subtypen entdeckt werden, welche als emm29.13, emm36.7 sowie emm75.5 erstbeschrieben und deren Sequenzen in der Datenbank des CDC hinterlegt wurden. Über die gesamte Kohorte hinweg wurde Typ emm12 bei 19% aller Fälle gefunden und lag somit am häufigsten vor, gefolgt von emm1 und emm4 mit je 14% sowie emm28 und emm89 mit je 11%. Bei Betrachtung der emm-Cluster zeigte sich E4 mit 31% am häufigsten, danach folgten Cluster A-C4 mit 19%, A-C3 und E1 mit jeweils 14%. Unter den 405 Fällen mit GAS-Tonsillopharyngitis lag emm12 mit knapp 20% am häufigsten vor, gefolgt von emm4 mit 15%, emm1 mit 14%, emm89 mit 13% und emm28 sowie emm3 mit je 9%. Hinsichtlich der Cluster wurde E4 dort mit knapp 30% am häufigsten festgestellt, gefolgt von A-C4 mit 20%, E1 mit 15%und A-C3 mit 14%. In der vorliegenden Studie konnte gezeigt werden, dass sich die emm-Typ- sowie die emm-Cluster-Epidemiologie in Abhängigkeit von der klinischen Manifestation unterscheidet. Auch wenn sich die Verteilungen grundsätzlich ähnelten, traten emm4 bzw. die Cluster A-C5 und E1 bei Patienten mit Tonsillopharyngitis mit Scharlach auch nach Bonferroni-Korrektur signifikant häufiger auf als bei solchen mit Tonsillopharyngitis ohne Scharlach. Erste Hinweise hierfür wurden im Rahmen dieser Arbeit in einer Vorabauswertung zu dieser Kohorte 2013 erstmals beschrieben und durch Ergebnisse folgender, internationaler Studien gestützt. Bei anogenitalen Infektionen wurde in knapp 80% der Fälle Cluster E4 und in 58% emm28 festgestellt, so-dass hier ein deutlich eingeengtes Erregerspektrum vorlag. Verglichen zu allen Fällen mit Tonsillopharyngitis wurden bei anogenitaler Infektion Typ emm28 und Cluster E4 signifikant häufiger isoliert. Für Hautinfektionen konnte kein signifikanter Unterschied der emm-Typ-Verteilung im Vergleich zu Racheninfektionen insgesamt gefunden werden. Es zeigte sich jedoch Cluster E4 signifikant häufiger bei Patienten mit einer Hautinfektion als bei solchen mit Scharlach. Insgesamt zeigte sich im konkreten Vergleich zu einer französischen Studie eine weitgehende Übereinstimmung hinsichtlich der Epidemiologie der emm-Typen und -Cluster, jedoch auch einzelne Differenzen. Diese Unterschiede waren signifikant für emm6 und emm22, ebenso wie für Cluster M6. Weiterhin bestätigte unter anderen die Studie von d´Humieres et al. die Häufung von emm4 bei Scharlach-Patienten, was die Aussage der vorgelegten Ergebnisse unter-streicht. Weiterhin wurde zur Untersuchung der longitudinalen Entwicklung der emm-Typen und emm-Cluster die Verteilung des Zeitraumes vom 01.04.2006 und 31.03.2007 mit dem vom 01.05.2011 bis 30.04.2012 verglichen. Zumindest für den vergleichsweise kurzen zeitlichen Abstand konnten nach Adjustierung keine signifikanten Veränderungen der Epidemiologie hinsichtlich einzelner emm-Typen bzw. -Cluster beobachtet werden. In bisherigen Studien wurde die Pathogenität eines Stammes meist anhand des klinischen Erscheinungsbildes bestimmt. In dieser Studie wurde weiterführend untersucht, inwiefern sich einzelne emm-Typen bzw. emm-Cluster auch in quantitativ messbaren Parametern wie u.a. dem C-reaktiven Protein (CRP) sowie der Leukozytenzahl im Blut unterscheiden. Bei Patienten mit Tonsillopharyngitis zeigte sich lediglich Cluster E4 signifikant häufiger mit einem CRP-Wert über 35 mg/l assoziiert. Für die Leukozytenzahl war ein solcher Zusammenhang dagegen nicht nachweisbar. Da die verwendeten Analysen jedoch Störfaktoren unterlagen und ein Kausalzusammenhang zwischen der Pathogenität des Erregers und der Auslenkung der ge-nannten Parameter im Rahmen des Studiendesigns nicht bewiesen werden konnte, lassen diese Ergebnisse keine abschließende Beurteilung zu. Der bereits entwickelte 30-valente Impfstoff zeigte anhand der enthaltenen M-Antigene eine gute Übereinstimmung mit den in dieser Studie gefundenen emm-Typen. Dabei waren die Antigene von 19 der 25 in dieser Studie registrierten emm-Typen in dem Impfstoff enthalten, was jedoch unter Berücksichtigung der Kreuzreaktivitäts-Hypothese für emm-Cluster zu einem Deckungsgrad von 99,8% aller untersuchten Fälle (565 von 566) führt. Insgesamt erwies sich der unizentrische Charakter der hier vorgelegten Studie in gewisser Hinsicht als Vorteil gegenüber multizentrischen Studien, da hierdurch zu bestimmten Fragen Informationen ohne den Einfluss regionaler Besonderheiten ausgewertet werden konnten. Inwiefern regionale Prävalenzen einzelner emm-Typen oder deren Pathogenitätspotential ent-scheidend für die Epidemiologie insbesondere invasiver Infektionen sind, kann anhand dieser Studie nicht abschließend beurteilt werden. Zur näheren Untersuchung dieses Sachverhaltes wären weiterführende Studien in größerem Maßstab notwendig. Zusammenfassend wurde mit dieser Arbeit eine umfassende epidemiologische Untersuchung anhand der molekularepidemiologischen Erregeranalyse unter Einschluss klinischer Aspekte an einer großen pädiatrischen Kohorte durchgeführt. Die gewonnenen Erkenntnisse leisten einen Beitrag zur Aufklärung der regionalen wie auch internationalen Epidemiologie von GAS und bieten wichtige Grundlagen sowie Ansätze für nachfolgende Untersuchungen, insbesondere für die Impfstoffentwicklung gegen GAS.:1 Einleitung 7
2 Theoretische Grundlagen 8
2.1 Epidemiologie 8
2.2 Taxonomie 10
2.3 Infektionspathologie 11
2.4 Aufbau des M-Proteins 14
2.5 Die Bedeutung des M-Proteins 16
2.6 emm-Genetik 18
2.7 Therapie und Prophylaxe 20
3 Ziele der Studie 22
4 Patienten, Material und Methoden 23
4.1 Mikrobiologische Isolate und klinische Daten 23
4.1.1 „Klinische Krankheitsbilder“ 25
4.1.2 Modifizierter Centor-Score 26
4.1.3 Grunderkrankungen 27
4.1.4 Paraklinik 27
4.2 Geräte und Materialien 29
4.2.1 Geräte und Hilfsmittel 29
4.2.2 Verbrauchsmaterialien 30
4.2.3 Molekulare Diagnostiksysteme 31
4.2.4 Primer für PCR und Sequenzierung 31
4.2.5 Medien und Lösungen 31
4.3 Mikrobiologische Methoden 32
4.3.1 Mikrobiologische Proben 32
4.3.2 Kultur von GAS 32
4.3.3 Latex-Agglutinationstest auf Gruppe A Antigen 33
4.3.4 Kryokonservierung der Isolate 34
4.4 Molekulargenetische Methoden 35
4.4.1 DNA-Isolierung 35
4.4.2 Photometrische Bestimmung der DNS-Konzentration und Einstellung 36
4.4.3 Polymerase-Kettenreaktion (PCR) 37
4.4.4 Agarose-Gelelektrophorese 37
4.4.5 DNA Sequenzierung 39
4.4.6 Sequenz-basierte Typisierung 41
4.5 Statistische Auswertung 42
5 Ergebnisse 43
5.1 Ausgewertete mikrobiologische Proben und retrospektive Daten 43
5.2 Analyse der Kohorte 45
5.2.1 Analyse der Altersverteilung 45
5.2.2 Analyse der Geschlechtsverteilung 48
5.2.3 Analyse der saisonalen Verteilung 49
5.2.4 Analyse der klinischen Symptome 51
5.2.5 Analyse von Vorerkrankungen und Versorgungsform 55
5.3 Laborbefunde 58
5.3.1 Analyse der semiquantitativen Wachstumsdichte der Abstrich-Kulturen 58
5.3.2 Blutparameter: C-Reaktives Protein (CRP) 59
5.3.3 Blutparameter: Leukozytenzahl 59
5.4 Molekulare Epidemiologie des emm-Typs 60
5.5 Erstbeschreibung neuer emm-Subtypen 60
5.6 emm-Typ- bzw. Cluster-Verteilung und klinische Manifestation 61
5.6.1 emm-Verteilung bei Tonsillopharyngitis 61
5.6.2 emm-Verteilung bei akuter Otitis media (AOM) 63
5.6.3 emm-Verteilung bei Hautinfektionen 64
5.6.4 emm-Verteilung bei anogenitalen Infektionen 65
5.6.5 emm-Verteilung bei invasiven Infektionen 68
5.6.6 emm-Verteilung bei asymptomatischer Rachen-Kolonisierung 68
5.7 Analyse der Altersverteilung für emm-Typen und -Cluster 70
5.8 Infektionsparameter und Korrelation zur molekularen Epidemiologie 71
5.8.1 Temperatur: 71
5.8.2 CRP: 72
5.8.3 Leukozytenzahl: 73
5.9 Patienten mit wiederholten Vorstellungen 73
5.9.1 Antibiotische Therapie 75
5.10 Resistenzlage 76
5.11 Analyse der molekularen Epidemiologie über der Zeit 78
6 Diskussion 80
6.1 Vorbemerkung 80
6.2 Kohorte 81
6.2.1 Alter 81
6.2.2 Geschlecht 82
6.2.3 Jahreszeit 82
6.2.4 Vorerkrankungen 83
6.2.5 Klinische Symptome 84
6.2.6 Diagnostischer Wert der semiquantitativen Wachstumsdichte 85
6.2.7 Rezidive 85
6.3 emm-Typ und –Cluster-Epidemiologie 86
6.3.1 emm-Typen und -Cluster bei Tonsillopharyngitis 86
6.3.2 emm-Typen und –Cluster bei Anogenitalinfektionen 86
6.3.3 emm-Typen und -Cluster bei invasiven Infektionen 87
6.3.4 emm-Typ und -Cluster-Epidemiologie im Vergleich zu anderen Studien 87
6.3.5 Longitudinale Betrachtung der emm-Typ-Epidemiologie 91
6.3.6 Vergleich der emm-Typen und Cluster-hinsichtlich des Alters der Patienten 92
6.3.7 emm-Typen und -Cluster hinsichtlich Infektionsparametern 92
6.3.8 Deckungsgrad mit 30-valentem M-Protein-basiertem GAS-Impfstoff 95
6.3.9 emm-Typ / -Cluster – Antibiotika-Resistenz 96
6.4 Ausblick 97
7 Zusammenfassung 98
8 Summary 101
9 Anhang 104
10 Abbildungsverzeichnis 112
11 Tabellenverzeichnis 114
12 Abkürzungsverzeichnis 116
13 Literaturverzeichnis 118
14 Anlage 1 127
15 Anlage 2 129
16 Danksagung 131 / Although - since the introduction of penicillin - there has been an effective drug against strep-tococci of Lancefield Group A (GAS), in which no resistance has been described so far, GAS infections remain a major healthcare policy problem, which affects both morbidity and mortality of people worldwide. GAS can cause a wide range of disorders in humans. These include un-complicated pharyngeal infections with and without scarlet fever as well as skin infections such as erysipelas or impetigo but also invasive as well as secondary complications. In 1928, the M-protein encoded by the emm gene was described as a type-specific, antibody -inducing substance and has since been used to characterize the epidemiology of GAS. One of the main functions of the M protein, anchored on the surface of GAS, is to evade phagocytosis by polymorphonuclear leukocytes, which is one of the most important defense mechanisms against infections by GAS. Although major efforts have been made for several decades, a safe and effective vaccine remains an unreached goal. In this study, the regional epidemiology of infections of pediatric patients by GAS was retro-spectively investigated on the basis of data and isolates collected from 11.03.2006 to 19.05.2012 at the University Medical Center in Freiburg. With a total of 566 isolates and asso-ciated clinical data, the present study provides the largest uni-centric epidemiological study of pediatric diseases with emm-typing of GAS so far in Germany. Particular attention was paid to associations between molecular epidemiology, based on emm-typing, and anonymized clinical data. The total cohort included 566 cases, thereof 405 cases of pharyngeal infection, 75 of which were additionally diagnosed with scarlet fever, 34 children presented with a skin infection, 21 with an acute otitis media, 19 with an anogenital infection, eight with an invasive infection and two with an urinary tract infection. In 77 cases colonization by GAS was estimated as having no clinical relevance of those 48 isolates were isolated from pharyngeal swabs.
In the molecular investigation, three new emm subtypes were discovered which were first de-scribed as emm29.13, emm36.7 as well as emm75.5. These sequences were entered into the database of the CDC. Over the entire cohort, emm12 was found in 19% of all cases and was thus the most frequent, followed by emm1 and emm4, with 14% each, emm28 and emm89, with 11% each. When considering emm-clusters, E4 was the most frequent with 31%, followed by cluster A-C4 with 19%, A-C3 and E1 with 14%. Among the 405 cases with GAS-related pharyngeal infection, emm12 was the most common with almost 20%, followed by emm4 with 15%, emm1 with 14%, emm89 with 13% and emm28 as well as emm3 with 9% each. With respect to the clus-ters, E4 was found to be the most common with around 30%, followed by A-C4 with 20%, E1 with 15% and A-C3 with 14%. In the present study it was shown that emm-types as well as emm-clusters differed depending on the clinical manifestation. Although the distributions were basically similar, emm4 as well as clusters A-C5 and E1 were significantly more common in patients with tonsillopharyngitis and scarlet fever, even after Bonferroni correction, than those with tonsillopharyngitis but without the diagnosis of scarlet fever. These findings were first described in a preliminary evaluation of this cohort in 2013 and supported by the results of consecutively published international stud-ies. In anogenital infections, cluster E4 was found in almost 80% and emm28 in 58%, indicat-ing a clearly narrowed spectrum. Compared to cases with tonsillopharygitis, emm28 and clus-ter E4 were significantly more frequently isolated in anogenital infections. For skin infections no significant difference could be found in the emm-distribution compared to tonsillopharyngi-tis. However, cluster E4 was found to be significantly more common in patients with a skin infection than in those with scarlet fever.
Overall, in a direct comparison to a French study, there was a wide agreement regarding the epidemiology of emm-types and -clusters, but also some differences. These differences were significant for emm6, emm22, as well as for cluster M6. Furthermore, among others, the study by d´Humieres et al. confirmed the accumulation of emm4 in scarlet fever patients, which un-derlines the statement of the presented results. Furthermore, in order to investigate the longitudinal development of emm-types and emm-clusters, the distribution in the period from 01.04.2006 to 31.03.2007 was compared to that from 01.05.2011 to 30.04.2012. At least for the comparatively short period, no significant changes in the epidemiology of individual emm-types or -clusters could have been observed after adjusting the p-values. In previous studies, the pathogenicity of a strain was determined by its association to the clini-cal picture. In addition, this study investigated the extent to which individual emm-types or emm-clusters also differed in quantitatively measurable parameters such as the C-reactive protein (CRP) and the leukocyte count in the blood. In cases of tonsillopharyngitis, cluster E4 was found significantly associated with a CRP value above 35 mg/l. For the leukocyte count such a difference was not detectable. However, since the values were subject to confounding factors, a causal link between pathogenicity of certain emm-types and the deflection of the mentioned parameters could not be proved within the framework of this study. Therefore, these results do not allow to draw final conclusions. The existing 30-valent M-protein based vaccine would show a good agreement with the corre-sponding emm-types of the cohort used here. The antigens of 19 of the 25 different emm-types registered in this study were included in the vaccination model, which corresponds to a vaccine coverage of 99.8% (565 of 566) of all strains examined here, if cross-reactivity of GAS strains within an emm-cluster was taken into consideration. Overall, the uni-centric character of the study presented here provided in certain aspects an advantage over multi-centric studies, as differences and similarities between different clinical pictures, excluding regional differences as well as comprehensive clinical information on the cases, could be emphasized. The extent to which regional prevalence of individual emm-types or their pathogenicity potential are decisive for the epidemiology of invasive infections could not be conclusively assessed by this study. For a closer look at this issue, further studies on a larger scale would be necessary. In summary, this work presents a comprehensive epidemiological investigation on molecular epidemiologic pathogen analysis including clinical aspects in a large pediatric cohort. The find-ings contribute to the elucidation of the regional an international epidemiology of GAS and pro-vide important basics as well as approaches for subsequent investigations, especially for vac-cine development against GAS.:1 Einleitung 7
2 Theoretische Grundlagen 8
2.1 Epidemiologie 8
2.2 Taxonomie 10
2.3 Infektionspathologie 11
2.4 Aufbau des M-Proteins 14
2.5 Die Bedeutung des M-Proteins 16
2.6 emm-Genetik 18
2.7 Therapie und Prophylaxe 20
3 Ziele der Studie 22
4 Patienten, Material und Methoden 23
4.1 Mikrobiologische Isolate und klinische Daten 23
4.1.1 „Klinische Krankheitsbilder“ 25
4.1.2 Modifizierter Centor-Score 26
4.1.3 Grunderkrankungen 27
4.1.4 Paraklinik 27
4.2 Geräte und Materialien 29
4.2.1 Geräte und Hilfsmittel 29
4.2.2 Verbrauchsmaterialien 30
4.2.3 Molekulare Diagnostiksysteme 31
4.2.4 Primer für PCR und Sequenzierung 31
4.2.5 Medien und Lösungen 31
4.3 Mikrobiologische Methoden 32
4.3.1 Mikrobiologische Proben 32
4.3.2 Kultur von GAS 32
4.3.3 Latex-Agglutinationstest auf Gruppe A Antigen 33
4.3.4 Kryokonservierung der Isolate 34
4.4 Molekulargenetische Methoden 35
4.4.1 DNA-Isolierung 35
4.4.2 Photometrische Bestimmung der DNS-Konzentration und Einstellung 36
4.4.3 Polymerase-Kettenreaktion (PCR) 37
4.4.4 Agarose-Gelelektrophorese 37
4.4.5 DNA Sequenzierung 39
4.4.6 Sequenz-basierte Typisierung 41
4.5 Statistische Auswertung 42
5 Ergebnisse 43
5.1 Ausgewertete mikrobiologische Proben und retrospektive Daten 43
5.2 Analyse der Kohorte 45
5.2.1 Analyse der Altersverteilung 45
5.2.2 Analyse der Geschlechtsverteilung 48
5.2.3 Analyse der saisonalen Verteilung 49
5.2.4 Analyse der klinischen Symptome 51
5.2.5 Analyse von Vorerkrankungen und Versorgungsform 55
5.3 Laborbefunde 58
5.3.1 Analyse der semiquantitativen Wachstumsdichte der Abstrich-Kulturen 58
5.3.2 Blutparameter: C-Reaktives Protein (CRP) 59
5.3.3 Blutparameter: Leukozytenzahl 59
5.4 Molekulare Epidemiologie des emm-Typs 60
5.5 Erstbeschreibung neuer emm-Subtypen 60
5.6 emm-Typ- bzw. Cluster-Verteilung und klinische Manifestation 61
5.6.1 emm-Verteilung bei Tonsillopharyngitis 61
5.6.2 emm-Verteilung bei akuter Otitis media (AOM) 63
5.6.3 emm-Verteilung bei Hautinfektionen 64
5.6.4 emm-Verteilung bei anogenitalen Infektionen 65
5.6.5 emm-Verteilung bei invasiven Infektionen 68
5.6.6 emm-Verteilung bei asymptomatischer Rachen-Kolonisierung 68
5.7 Analyse der Altersverteilung für emm-Typen und -Cluster 70
5.8 Infektionsparameter und Korrelation zur molekularen Epidemiologie 71
5.8.1 Temperatur: 71
5.8.2 CRP: 72
5.8.3 Leukozytenzahl: 73
5.9 Patienten mit wiederholten Vorstellungen 73
5.9.1 Antibiotische Therapie 75
5.10 Resistenzlage 76
5.11 Analyse der molekularen Epidemiologie über der Zeit 78
6 Diskussion 80
6.1 Vorbemerkung 80
6.2 Kohorte 81
6.2.1 Alter 81
6.2.2 Geschlecht 82
6.2.3 Jahreszeit 82
6.2.4 Vorerkrankungen 83
6.2.5 Klinische Symptome 84
6.2.6 Diagnostischer Wert der semiquantitativen Wachstumsdichte 85
6.2.7 Rezidive 85
6.3 emm-Typ und –Cluster-Epidemiologie 86
6.3.1 emm-Typen und -Cluster bei Tonsillopharyngitis 86
6.3.2 emm-Typen und –Cluster bei Anogenitalinfektionen 86
6.3.3 emm-Typen und -Cluster bei invasiven Infektionen 87
6.3.4 emm-Typ und -Cluster-Epidemiologie im Vergleich zu anderen Studien 87
6.3.5 Longitudinale Betrachtung der emm-Typ-Epidemiologie 91
6.3.6 Vergleich der emm-Typen und Cluster-hinsichtlich des Alters der Patienten 92
6.3.7 emm-Typen und -Cluster hinsichtlich Infektionsparametern 92
6.3.8 Deckungsgrad mit 30-valentem M-Protein-basiertem GAS-Impfstoff 95
6.3.9 emm-Typ / -Cluster – Antibiotika-Resistenz 96
6.4 Ausblick 97
7 Zusammenfassung 98
8 Summary 101
9 Anhang 104
10 Abbildungsverzeichnis 112
11 Tabellenverzeichnis 114
12 Abkürzungsverzeichnis 116
13 Literaturverzeichnis 118
14 Anlage 1 127
15 Anlage 2 129
16 Danksagung 131
|
79 |
The Role of the sia and siu ABC-Type Transporters in Iron Utilization and Virulence in Streptococcus pyogenesMontanez, Griselle Enid 12 January 2006 (has links)
A limited understanding of iron uptake mechanisms is available for Streptococcus pyogenes, a hemolytic human pathogen capable of using a variety of hemoproteins in addition to ferric and ferrous iron. This study characterizes the transporters of iron-complexes siuADBG (for streptococcal iron uptake) and siaABC (for streptococcal iron acquisition). These ABC-type transporters are encoded by iron regulated operons and their protein products are homologous to components of heme and siderophore transporters found in both Gram-positive and Gram-negative bacteria. Mutants of the membrane permeases siuG and siaB were constructed and characterized. Mutations in both transporters demonstrated growth reduction in comparison to the parent strain when grown in complex medium containing iron in the form of hemoglobin. The addition of heme to the growth medium inhibited ferric uptake by the wild-type while the addition of protoporphyrin IX did not, suggesting that heme utilization as an iron source is responsible for the inhibition of ferric accumulation. Inactivation of siuG reduced the ability of heme to inhibit ferric incorporation by the cells. Inactivation of siaB in addition to siuG had a cumulative effect, indicating that both siu and sia transporters are involved in heme utilization. We also demonstrated that purified rSiaA, the surface receptor of SiaABC, binds heme and hemoglobin in vitro, and we propose a mechanism of heme binding by SiaA. Studies in a zebrafish infection model revealed that the siuG mutant was attenuated in producing disease. While the siaB mutant also presented virulence attenuation, infection by this mutant was characterized by an increase in the host inflammatory response. These observations show that iron acquisition is important for S. pyogenes virulence. We propose that the SiaABC and SiuADBG, together with the multi-metal transporter MtsABC, are involved in iron acquisition from different iron sources present in the human body, thus contributing to the survival and pathogenesis of S. pyogenes.
|
80 |
Transcriptional regulation of the MGA virulence regulon in Streptococcus pyogenesAlmengor, Audry C. January 2005 (has links)
Thesis (Ph.D.) -- University of Texas Southwestern Medical Center at Dallas, 2005. / Partial embargo. Vita. Bibliography: 154-191.
|
Page generated in 0.0767 seconds